Twin Securities’s Apellis Pharmaceuticals APLS Stock Holding History

Twin Securities’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-127,440	Closed	-$5.13M	–	15
2026 Q1	$5.13M	Buy	+127,440	New	+$2.75M	2.49%	8

Other funds holding APLS

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Twin Securities's APLS Position: Q2 2026 in Review

Twin Securities sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 127,440 shares — an estimated $5.13M sold.

Twin Securities first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $5.13M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Twin Securities reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Twin Securities sold 127,440 Apellis Pharmaceuticals shares in Q2 2026, an estimated $5.13M.
Twin Securities first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Twin Securities's Apellis Pharmaceuticals position peaked at $5.13M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Twin Securities's 13F filing for Q2 2026, filed 14 Aug 2026.